…n the rate of decline was 2.98 (95% CI 1.67, 4.29) in favour of edaravone, a clinically important 40% reduction versus placebo. Safety an…
4articles mentioning drugs
17drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Edaravone ×
Edaravone
This drug is selected. Its supporting articles are shown below.
Articles mentioning Edaravone
4 articles · page 1 of 1edaravoneamyotrophic lateral sclerosisALSStudy19ALS-Functional-Rating-Scale-RevisedStudy16Pharmaceutical Benefits SchemePBSNCT00330681
EdaravoneALSPharmaceutical Benefits SchemeTGA Special Access SchemePBSTGATherapeutic Goods AdministrationHASO
… alleviates the stress of travelling to hospital for treatment. Edaravone infusions at home are safe.…
edaravoneESTCerebral small vessel disease (CSVD)CSVD-CICSVD
…VD-related cognitive impairment (CSVD-CI) are limited. Although edaravone has shown potential in alleviating CSVD’s pathophysiological ch…
edaravone dexborneoledaravoneacute ischaemic strokeNIH Stroke Scale
…set who underwent endovascular thrombectomy, those treated with edaravone dexborneol, compared with placebo, were more likely to achieve functional …